An exodus of pharma R&D leaders to small biotechs and start-ups over the last year reflects a new phase in the ecosystem’s churn of talent.
contact@paulpetertak.com
Privacy Policy
© Paul Peter Tak.All rights reserved.
LinkedIn
Wiki
Google Scholar
Pub Med
